Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IOngoingFeb 7, 2024VANCOmycin HCl PF 1.5g added to 0.9% Sodium Chloride 250 mL IV bagSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0282-2024Class IOngoingFeb 7, 2024VANCOmycin HCl PF 1.25g added to 0.9% Sodium Chloride 250 mL IV bagSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0281-2024Class IOngoingFeb 7, 2024PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium ChlorideSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0280-2024Class IOngoingFeb 7, 2024PHENYLephrine HCl 20 mg per 250 mL 0.9% Sodium ChlorideSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0279-2024Class IOngoingFeb 7, 2024FentaNYL citrate PFSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0278-2024Class IOngoingFeb 7, 2024FentaNYL citrate PFSuperpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.Denver Solutions, LLC DBA Leiters Health · D-0277-2024Class IITerminatedFeb 7, 2024Budesonide Extended-Release TabletsFailed Dissolution SpecificationsGolden State Medical Supply Inc. · D-0276-2024Class IIOngoingFeb 7, 2024Budesonide Extended-Release Tablets 9mgFailed Dissolution SpecificationsTeva Pharmaceuticals USA, Inc · D-0275-2024Class IITerminatedFeb 7, 2024Cefixime for Oral Suspension 100mg/5mLFailed Impurities/Degradation SpecificationsLupin Pharmaceuticals Inc. · D-0274-2024Class ITerminatedJan 31, 2024Robitussin Honey CF Max Nighttime AdultMicrobial Contamination of Non-Sterile ProductsHaleon US Holdings LLC · D-0317-2024Class ITerminatedJan 31, 2024Robitussin Honey CF Max Non-Drowsy AdultMicrobial Contamination of Non-Sterile ProductsHaleon US Holdings LLC · D-0316-2024Class IICompletedJan 31, 2024Fexofenadine Hydrochloride TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0273-2024Class IICompletedJan 31, 2024Zolpidem Tartrate Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0272-2024Class IICompletedJan 31, 2024Zolpidem Tartrate Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0271-2024Class IICompletedJan 31, 2024Niacin Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0270-2024Class IICompletedJan 31, 2024Niacin Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0269-2024Class IICompletedJan 31, 2024Mesalamine Delayed-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0268-2024Class IICompletedJan 31, 2024Lurasidone Hydrochloride Tablets 120mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0267-2024Class IICompletedJan 31, 2024Lurasidone Hydrochloride Tablets 60mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0266-2024Class IICompletedJan 31, 2024Febuxostat Tablets 80 mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0265-2024Class IICompletedJan 31, 2024Febuxostat Tablets 40mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0264-2024Class IICompletedJan 31, 2024Cinacalcet Tablets 60mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0263-2024Class IITerminatedJan 31, 2024Fosaprepitant for Injection 150 mg per vialLack of Sterility Assurance: Aseptic process simulation failure.Be Pharmaceuticals AG · D-0262-2024Class IOngoingJan 31, 2024Bleomycin for InjectionPresence of particulate matter: glassPfizer · D-0261-2024Class IITerminatedJan 31, 2024Methoxsalen CapsulesFailed Dissolution SpecificationsStrides Pharma Inc. · D-0260-2024Class IITerminatedJan 31, 2024Fluocinolone Acetonide OilFailed Excipient Specifications: OOS for assay of Isopropyl AlcoholGlenmark Pharmaceuticals Inc., USA · D-0259-2024Class IIOngoingJan 31, 2024Vasopressin 2 Unit/2 mL in 0.9% Sodium ChlorideSubpotent DrugIntegraDose Compounding Services LLC · D-0258-2024Class IIIOngoingJan 31, 2024Benzonatate CapsulesSuperpotent drug: Assay results were slightly above specification at the time zero point.Amerisource Health Services LLC · D-0257-2024Class IITerminatedJan 24, 2024Secret Dry SprayCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0256-2024Class IITerminatedJan 24, 2024Secret, Dry SprayCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0255-2024Class IITerminatedJan 24, 2024Secret, Dry SprayCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0254-2024Class IITerminatedJan 24, 2024Secret, powder freshCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0253-2024Class IITerminatedJan 24, 2024Old SpiceCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0252-2024Class IITerminatedJan 24, 2024Old SpiceCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0251-2024Class IITerminatedJan 24, 2024Old SpiceCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0250-2024Class IITerminatedJan 24, 2024Old Spice Pure Sport 2021 Gift SetCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0249-2024Class IITerminatedJan 24, 2024Secret OUTLAST Dry SprayCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0248-2024Class IITerminatedJan 24, 2024Secret, OUTLASTCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0247-2024Class ITerminatedJan 24, 2024Secret, Dry SprayChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0246-2024Class IITerminatedJan 24, 2024Secret, Dry SprayCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0245-2024